(Q28327318)

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

23 May 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

23 May 2023

author name string

W. V. Fairchild

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459006

3 July 2022

C. R. Spence

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459006

3 July 2022

H. D. Solomon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459006

3 July 2022

M. P. Gangai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459006

full work available at URL

3 July 2022

language of work or name

English

0 references

publication date

August 1979

0 references

https://api.elsevier.com/content/article/PII:S0022534717563065?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

https://api.elsevier.com/content/article/PII:S0022534717563065?httpAccept=text/plain

23 May 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2956306-5

23 May 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

23 May 2023

0 references

122

0 references

issue

2

0 references

page(s)

163-4

0 references

cites work

Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJM197508072930604

Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Cytotoxic drugs in treatment of nonmalignant diseases

23 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Urological Complications of Cyclophosphamide

23 May 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy

23 May 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Cyclophosphamide and the bladder

23 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Transitional cell carcinoma of the bladder associated with cyclophosphamide

23 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

23 May 2023

Letter: Cyclophosphamide

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Letter: Cytokinetic studies in patients with neoplasia

23 May 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Carcinoma of the Bladder complicating Cyclophosphamide Therapy

23 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Population trends in cigarette smoking and bladder cancer

23 May 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Tumors of the urinary bladder

23 May 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

CYTOLOGICAL STUDY OF THE EFFECT OF CYCLOPHOSPHAMIDE ON THE EPITHELIUM OF THE URINARY BLADDER IN MAN

23 May 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

Selective depletion of lymphoid tissue by cyclophosphamide

23 May 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56306-5

23 May 2023

Identifiers

0 references